Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

New IL-17RA antagonists presented by Hitgen

Jan. 31, 2022

BeiGene discloses non-receptor tyrosine-protein kinase TYK2 inhibitors

Jan. 17, 2022

Researchers develop a novel murine model of Cockayne syndrome

Jan. 14, 2022

CD6-ALCAM pathway is a therapeutic target in SLE

Jan. 12, 2022

InflaRx advances oral C5aR inhibitor INF-904 toward clinic

Jan. 11, 2022

Modulating CYTOR promotes myogenesis in aging

Jan. 7, 2022

Kyverna licenses CAR T construct for use in autologous and allogeneic therapies

Jan. 4, 2022

New RIPK1 inhibitors discovered at Sanofi

Dec. 29, 2021

Noncanonical NLRC4 inflammasome mechanism offers new targets for sterile inflammatory disorders

Dec. 23, 2021

IL-27-producing natural regulatory B-1a cells protect from CNS autoimmune diseases

Dec. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...